Rosuvastatin and ezetimibe combination reduced heart vessel plaques by 21% over a year and a half
Danish researchers published in JAMA Cardiology the results of a study in which intensive cholesterol therapy led to a reduction in the volume of atherosclerotic plaques in the coronary arteries. The combination regimen proved more effective than monotherapy, but the conclusions are limited by a small sample.
Otabek Yusupov